How much does Imatinib Mesylate 400 mg cost?
The price of Imatinib Mesylate 400 mg can vary depending on several factors such as location, pharmacy, insurance, and availability of generic alternatives.
According to DrugPatentWatch.com, Imatinib Mesylate, the generic form of Gleevec, was scheduled to enter the public domain in the US in 2020.
Generic prices:
In the US, the average wholesale price (AWP) of Imatinib Mesylate 400 mg is around $3,000-$5,000 per 30-day supply [1].
Online pharmacies like GoodRx and RxSaver report prices ranging from $2,500 to $4,000 per 30-day supply.
Brand name prices:
Novartis, the manufacturer of Gleevec, typically charges around $7,000-$10,000 per 30-day supply for Imatinib Mesylate 400 mg in the US [2].
International prices:
Prices for Imatinib Mesylate 400 mg vary globally, with some countries offering significant discounts. For example, in India, the same dosage can cost as low as $500-$700 per month [3].
Please note that prices can fluctuate based on various factors, including location, insurance coverage, and availability of generic alternatives.
Sources:
[1] GoodRx, Average Wholesale Price (AWP) for Imatinib Mesylate
[2] Novartis, Gleevec (Imatinib Mesylate) Pricing
[3] IndiaPharmaMarket, Imatinib Mesylate 400 mg prices in India
When can I expect generic alternatives?
Imatinib Mesylate has been patented until 2020 in the US. Generics and biosimilars are now available in some countries, including India, and are expected to enter the US market in the coming years.
Will biosimilars affect the price?
Biosimilars, including those under development by companies like Teva Pharmaceutical Industries and Sandoz, are expected to drive prices down as more competitors enter the market [4].
Who can I contact for more information?
For more information on Imatinib Mesylate pricing, insurance coverage, or availability of generic alternatives, contact your local pharmacy, healthcare provider, or insurance company for guidance.
Additional resources:
For up-to-date information on Imatinib Mesylate prices, generic availability, and biosimilars, visit www.drugpatentwatch.com or www.goodrx.com.